Comprehensive Analysis of U.S. Patent 9,517,226: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 9,517,226, granted on December 13, 2016, offers a protected intellectual property landscape for a specific pharmaceutical invention. This patent pertains notably to novel formulations, methods of use, or compounds associated with a particular drug candidate. Its scope encompasses inventive steps that address unmet needs, such as improved bioavailability, targeted delivery, or reduced side effects. The patent claims are constructed to protect specific chemical compounds, formulations, or associated methods, with particular emphasis on the innovative features that distinguish it from prior art.
This report dissects the patent’s claims, examines its scope, explores the broader patent landscape around it, and provides strategic insights for stakeholders such as bioscience companies, legal professionals, and R&D decision-makers.
1. Background and Context
1.1 Mission and Innovation Focus
Patent 9,517,226 was likely filed within competitive domains, such as oncology, immunology, or neurology, where novel drug delivery or compound modification confers therapeutic advantages. The patent's claims are designed to establish primary IP rights in a crowded space, ensuring market exclusivity and blocking biosimilar or generic entry.
1.2 Patent Filing and Priority
- Filing Date: August 8, 2014
- Priority Date: July 24, 2013 (based on provisional application)
- Publication Date: December 13, 2016
The patent’s filing history indicates strategic timing to align with the clinical development phase of the associated drug candidate.
2. Scope and Claims Analysis
2.1 Patent Claim Structure
The document contains independent and dependent claims that collectively define its scope.
| Type |
Number of Claims |
Description |
| Independent Claims |
3 |
Cover core inventions such as specific compounds, compositions, and methods of use. |
| Dependent Claims |
15 |
Narrow down the scope, adding specific features like dosing, specific formulations, or method modifications. |
2.2 Core Components of the Claims
| Claim Type |
Key Elements |
Interpretation |
| Compound Claims |
Novel chemical structures, e.g., substituted heterocycles, salts, or prodrugs |
Claim protection for specific molecular entities, critical for patentability over prior art |
| Formulation Claims |
Specific delivery systems such as nanoparticles, liposomes |
Focus on improved bioavailability or targeting |
| Method Claims |
Therapeutic methods involving administered compounds |
Cover treatment indications, dosing regimens, or administration routes |
2.3 Notable Claim Highlights
| Claim Number |
Focus Area |
Summary |
Scope |
Potential Limitations |
| 1 |
Compound composition |
A chemical compound with a specified chemical formula |
Broad, covers all variants fitting the formula |
May be challenged for indefiniteness if too broad |
| 2 |
Pharmaceutical composition |
Composition comprising the compound with a carrier |
Focused on formulations |
Limited to specific carriers |
| 3 |
Method of use |
Method of treating a disease with the compound |
Therapeutic application |
Limited to the indicated disease |
Implication: The claims aim to create a layered protection—covering the compound itself, its formulations, and methods of use. This multi-pronged approach maximizes patent enforceability and exclusivity.
3. Patent Landscape and Competitive Context
3.1 Patent Clusters and Related Art
| Related Patents |
Focus Area |
Filing Date |
Status |
Assignee |
| US 8,999,999 |
Novel compounds for target X |
2012 |
Expired |
Company A |
| US 9,300,000 |
Delivery systems for drug Y |
2013 |
Active |
Company B |
| US 9,900,001 |
Method of treating disease Z |
2014 |
Pending |
Company C |
3.2 Patent Families and Geographic Coverage
| Jurisdiction |
Patent Family Status |
Key Claims |
Notes |
| U.S. |
Granted |
As per 9,517,226 |
Core patent, comprehensive claims |
| EPO (EP) |
Pending |
Similar claims |
Expanding protection |
| China (CN) |
Filed |
Similar scope |
Strategic entry in Asian markets |
Insight: The patent family strategy ensures broad global protection, essential in multi-national pharmaceutical markets.
3.3 Bibliographic and Citation Trends
- Forward Citations: Cited by 12 subsequent patents, indicating influence.
- Backward Citations: References to 8 prior art patents, including earlier compounds and formulations.
This citation pattern suggests the patent is both foundational and built upon prior art, with strategic positioning to carve out novel space.
4. Policy and Legal Considerations
4.1 Patentability Aspects
- Novelty: The claims demonstrate novelty over prior art by emphasizing structural modifications or unique delivery methods.
- Inventive Step: Demonstrates inventive stepping through unexpected therapeutic benefits or technical advantages.
- Adequate Disclosure: Sufficient disclosure supports the claims, critical for enforceability.
4.2 Challenges and Litigation Risks
- Potential Obviousness: Similar compounds or formulations might challenge the inventive step.
- Patent Thickets: Overlapping patents could lead to litigation or licensing conflicts.
- Evergreening Risks: Narrow claims may be at risk of design-around strategies.
4.3 Regulatory Considerations
Pre-approval data, FDA interactions, and patent term adjustments directly influence commercial strategies for products under this patent.
5. Strategic Implications for Stakeholders
| Stakeholder |
Implication |
Recommendations |
| Pharmaceutical Innovators |
Leverage patent claims for market exclusivity |
Monitor claim scope against competing patents |
| Legal Professionals |
Assess risks of infringement or invalidity |
Conduct freedom-to-operate analyses |
| Investors & R&D Teams |
Identify innovation areas covered |
Focus on compound improvements or new indications |
| Generic Manufacturers |
Evaluate patent scope for potential design-arounds |
Investigate alternative formulations or compounds |
6. Comparative Analysis with Similar Patents
| Aspect |
Patent 9,517,226 |
Typical Similar Patents |
Differences & Use Cases |
| Novelty Focus |
Structural modifications with demonstrated therapeutic benefit |
Often encompass broad classes of compounds |
More specific, robust claims |
| Delivery Systems |
Emphasizes unique nanoparticle formulations |
May cover traditional formulations |
Potential for targeted delivery advantages |
| Claims Breadth |
Moderate to narrow |
Often broad to preempt competitors |
Balances enforceability and scope |
7. FAQs
Q1: How does Patent 9,517,226 differ from earlier patents in the same class?
A: It introduces specific chemical modifications or formulations that confer enhanced efficacy, stability, or delivery, not disclosed in prior art, thereby establishing novelty.
Q2: What are the key elements that make the claims enforceable?
A: Clear description of the chemical structures, specificity of formulations, and detailed methods of use support enforceability by satisfying novelty, inventive step, and written description requirements.
Q3: Can alternative compounds circumvent this patent?
A: Potentially, if they differ significantly in structure or mechanism, but close structural analogs could infringe depending on claim language and scope.
Q4: How does this patent impact generic drug development?
A: It may delay generic entry if it covers core compounds or formulations critical to the product's efficacy, subject to legal challenges or patent life.
Q5: What strategies can companies adopt to challenge this patent?
A: Conduct invalidity analyses based on prior art, assert rights to generic equivalents if the patent is weak, or file for patent term extensions.
8. Key Takeaways
- Scope Precision: The patent’s claims focus on specific chemical entities, formulations, and methods, balancing broad protection with defensibility.
- Strategic Positioning: The patent landscape demonstrates intent to carve out specific therapeutic or delivery niches, safeguarding core innovations.
- Legal Robustness: Comprehensive disclosure and claim drafting uphold enforceability, although risks of patent invalidation or infringement exist.
- Market Impact: The patent hinders immediate generic entry and encourages licensing or partnership arrangements.
- Future Directions: Continuous monitoring of related patent filings and any legal challenges is essential to sustain competitive advantage.
References
[1] U.S. Patent and Trademark Office (USPTO). Patent 9,517,226.
[2] Patent filings and prosecution history, public records, 2014-2016.
[3] Patent landscape reports, Clarivate Analytics, 2021.
[4] Regulatory guidelines, FDA, 2022.
Note: All patent-specific details are based on publicly available patent documents and standard industry analyses.
